uterine fibroids

FDA: New assessment discourages morcellation for fibroidsAn updated review of evidence by the US Food and Drug Administration (FDA) underscores concerns expressed in 2014 by the agency about use of laparoscopic power morcellators (LPM) for treatment of uterine fibroids. Plus: Prescription habits show ob/gyns not well informed about opioids, according to a study. Also: Does ADHD medication use during pregnancy increase risk of congenital malformations?
Radiofrequency ablation: A new paradigm for treatment of fibroids
Radiofrequency ablation: A new paradigm for treatment of fibroidsLess intervention and shorter downtime are two advantages to RFA.
FDA approves morcellation containment systemThe FDA approves the first containment system for morcellation. Plus: ASRM provides guidance for Zika virus. And, the impact of HRT timing and its impact on cardiovascular disease.
Puzzler: An unusual cause of pelvic painIt may difficult to arrive at a diagnosis in cases of acute pain.
Puzzler: A sneaky cause of hemorrhagic shockCan you arrive at the correct diagnosis?
Tool helps with decision-making for fibroid managementA clinical decision tool serves as a framework for providers to counsel patients about mode of hysterectomy.
The economics of uterine fibroidsA study tabulates the direct and indirect costs.
Uterine fibroids: medical management options
Uterine fibroids: medical management optionsFor women in whom surgery is not recommended or necessary, treatment with the goal of symptom relief and size reduction can be achieved medically.
SMFM consult: Fibroids in pregnancy: Meaning and ManagementQuestions and answers from SMFM about the implications of uterine fibroids during pregnancy
Product Review: Technologies for laparoscopic contained tissue extractionNewer surgical techniques to facilitate the extraction of uterine tumors in a containment system have sufficiently advanced to make the small risk of spreading an unanticipated malignancy even smaller.